The serotonin transporter and depression

Depression and Anxiety

Volumn 8, Issue SUPPL. 1, 1998, Pages 5-12

  Owens, Michael J ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; CITALOPRAM; DESIPRAMINE; DESVENLAFAXINE; FLUOXETINE; FLUVOXAMINE; HYDROXYNEFAZODONE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORFLUOXETINE; NORSERTRALINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; DEPRESSION; ELECTROCONVULSIVE THERAPY; EXON; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SUICIDE ATTEMPT;

ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER; HUMANS; SEROTONIN;

EID: 0031727557     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1998)8:1+<5::AID-DA2>3.0.CO;2-I     Document Type: Article

References (91)

1. Altemus M, Murphy DL, Greenberg B, Lesch KP (1996) Intact coding region of the serotonin transporter gene in obsessive-compulsive disorder. Am J Med Genet Neuropsychiat Genet 67:409-411.
2. Arango V, Underwood MD, Gubbi AV, Mann JJ (1995) Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral orefrontl cortex of suicide victims. Brain Res 688:121-133.
3. Asberg M, Traskman L, Thoren P (1976a) 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch Gen Psychiatry 33:1193-1197.
4. Asberg M, Thoren L, Traskman P (1976b) Serotonin depression: A biochemical subgroup within the affective disorders. Science 191:478-480.
5. Azmitia EC, Whitaker-Azmitia PM (1995) Anatomy, cell biology, and plasticity of the serotonergic system: Neuropsychopharmacological implications for the actions of psychotropic drugs. In Bloom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 443-450.
6. Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD (1997) Effects of selective serotoni reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry 41:184-190.
7. Ball D, Hill L, Freeman B, Eley TC, Strelau J, Riemann R, Spinath FM, Angleitner A, Plomin R (1997) The serotonin transporter gene and peer-related neuroticism. NeuroReport 8:1301-1304.
8. Barker EL, Blakely RD (1995) Norepinephrine and serotonin transporters: Molecular targets of antidepressant drugs. In Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 321-333.
9. Barker EL, Blakely RD (1996) Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. Mol Pharmacol 50:957-965.
10. Battersby S, Ogilvie AD, Smith CAD, Blackwood DHR, Muir WJ, Quinn JP, Fink G, Goodwin GM, Harmar AJ (1996) Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatry Genet 6:177-181.
11. 3H-imipramine binding in euthymic bipolar patients. Psychiatry Res 7:215-219.
12. Blakely RD, Berson HE (1992) Molecular biology of serotonin receptors and transporters. Clin Neuropharmacol 15:351A.
13. Bradley CC, Blakely RD (1997) Alternative splicing of the human serotonin transporter gene. J Neurochem 69:1356-1367.
14. Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E (1980) Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science 209:303-205.
15. Burnet PWJ, Michelson D, Smith MA, Gold PW, Sternberg EM (1994) The effect of chronic imipramine administration on the densities of 5-HT1A and 5-HT2 receptors and the abundancies of 5HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res 638:311-324.
16. - permeation and pH regulation at a mammalian serotonin transporter. J Neurosci 17:2257-2266.
17. Castroviovanni P, Di Muro A, Marazziti D (1995) Imipramine binding as a predictor of fluoxetine response in depressed patients. Neuropsychobiology 31:64-67.
18. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, Aitchison KJ, Sodhi M, Li T, Roberts GW, Smith B, Morton J, Murray RM, Smith D, Kirov G (1996) The serotonin transporter is a potential suseptibility factor for bipolar affective disorder. Neuroreport 7:1675-1679.
19. Da Prada M, Cesura AM, Launay JM, Richards JG (1988) Platelets as models for neurones? Experientia 44:115-126.
20. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action: Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411-418.
21. Delgado PL, Price LH, Miller HL, Salomon RM, Aghajanian GK, Heninger GR, Charney DS (1994) Serotonin and the neurobiology of depression: Effects of tryptophan depletion in drug-free depressed patients. Arch Gen Psychiatry 51: 865-874.
22. DeMet EM, Chicz-DeMet A (1996) Seasonal patterns in platelet ligand binding are related to membrane proteins. Biol Psychiatry 39:430-435.
23. de Montigny C, Aghajanian GK (1978) Tricyclic antidepressants: Long-term administration increases responsivity of rat forebrain neurons to serotonin. Science 202:1303-1306.
24. 3H-paroxetine binding in depressed patients. Psychiatry Res 26:11-17.
25. 3H]paroxetine to platelets of depressed patients: Seasonal differences and effects of diagnostic classification. J Affect Dis 32:27-35.
26. 3H]paroxetine binding in healthy volunteers. Neuropsychopharmacology 15:187-198.
27. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
28. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH (1997) No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionaire (TPQ) temperament of harm avoidance. Mol Psychiatry 2:224-226.
29. Elliot JM (1991) Peripheral markers in affective disorders. In Horton R, Katona C (eds): Biological Aspects of Affective Disorders. London: Academic Press, pp 95-144.
30. Ellis PM, Salmond C (1994) Is platelet imipramine binding reduced in depression? A meta analysis. Biol Psychiatry 36:292-299.
31. Freeman AM, Stankovic SMI, Bradley R, Zhang GZ, Libb W, Nemeroff CB (1993) Tritiated platelet imipramine binding and treatment response in depressed outpatients. Depression 1:20-23.
32. Galli A, Blakely RD, DeFelice LJ (1996) Norepinephrine transporters have channel modes of conduction. Proc Natl Acad Sci USA 93:8671-8676.
33. Galli A, Peterson CI, deBlaquiere M, Blakely RD, DeFelice LJ (1997) Drosophila serotonin transporters have voltage-dependent uptake coupled to a serotonin-gated ion channel. J Neurosci 17:3401-3411.
34. 2-adrenoceptor binding in normal subjects during desipramine administration and withdrawal. Neuropsychopharmacology 4:117-124.
35. Heils A, Teufel A, Petri S, Seemann M, Bengel D, Balling U, Riederer P, Lesch K-P (1995) Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. J Neural Transm 102:247-254.
36. Heils A, Teufel A, Petri S, Stöber G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624.
37. Heninger GR (1995) Indoleamines: The role of serotonin in clinical disorders. In Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, pp 471-482.
38. Hrdina PD, Demeter E, Vu TB, Sótónyi P, Palkovits M (1993) 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: Increase in 5-HT2 sites in cortex and amygdala. Brain Res 614:37-44.
39. Kraepelin E (1892) Über die Beeinflussung einfacher psychischer Vorgänge durch einige Arzneimittel. Jena: Fischer.
40. Kunugi H, Tatsumi M, Sakai T, Hattori M, Nanko S (1996) Serotonin transporter gene polymorphism and affective disorder. Lancet 347:1340.
41. Langer SZ, Galzin A-M (1988) Studies on the serotonin transporter in platelets. Experientia 44:127-130.
42. 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders. Life Sci 29:211-218.
43. 3H]paroxetine binding with the 5-HT transporter in brain and platelets: Relevance to studies in depression. J Receptor Res 7:499-521.
44. Lawrence KM, De Paermentier F, Cheetham SC, Crompton MR, Katona CLE, Horton RW (1990) Brain 5-HT uptake sites, labelled with [3H]-paroxetine, in antidepressant-free depressed suicides. Brain Res 526:17-22.
45. 3H]paroxetine. Psychopharmacology 110:235-239.
46. 3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine. Psychopharmacology 115:261-264.
47. Leake A, Fairbairn AF McKeith IG, Ferrier IN (1991) Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: Neurochemical and clinical correlates. Psychiatry Res 39:155-165.
48. Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL (1993a) Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 17:31-35.
49. Lesch K-P, Wolozin BL, Estler HC, Murphy DL, Riederer P (1993b) Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm 91:67-72.
50. Lesch K-P, Wolozin BL, Murphy DL, Reiderer P (1993c) Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter. J Neurochem 60:2319-2322.
51. Lesch K-P, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P (1994) Organization of the human serotonin transporter gene. J Neural Transm 95:157-162.
52. Lesch KP, Gross J, Franzek E, Wolozin BL, Riederer P, Murphy DL (1995) Primary structure of the serotonin transporter in unipolar depression and bipolar disorder. Biol Psychiatry 37:215-223.
53. Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1529.
54. Little KY, McLauglin DP, Ranc J, Gilmore J, Lopez JF, Watson SJ, Carroll FI, Butts JD (1997) Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide. Biol Psychiatry 41:1156-1164.
55. Lopez JF, Chalmers DT, Vázquez DM, Watson SJ, Akil H (1994) Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry 35:287-290.
56. Mager S, Min C, Henry DJ, Chavkin C, Hoffman BJ, Davidson N, Lester HA (1994) Conducting states of a mammalian serotonin transporter. Neuron 12:845-859.
57. Mann JJ, Underwood MD, Arango V (1996) Postmortem studies of suicide victims. In Watson SJ (ed): Biology of Schizophrenia and Affective Disease. Washington, DC: APA Press, pp 197-222.
58. 3H-paroxetine binding during treatment with psychoactive drugs. Biol Psychiatry 30:1056-1058.
59. Meltzer HY, Lowy MT (1987) The serotonin hypothesis of depression. In Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress. New York: Raven Press, pp 513-526.
60. Mongeau R, Blier P, de Montigny C (1997) The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments. Brain Res Rev 23:145-195.
61. 3H]imipramine binding sites in geriatric depression. Arch Gen Psychiatry 45:919-923.
62. Nemeroff CB, Knight DL, Franks J, Craighead WE, Krishnan KRR (1994) Further studies on platelet serotonin transporter binding in depression. Am J Psychiatry 151:1623-1625.
63. Neumaier JF, Root DC, Hamblin MW (1996) Chronic fluoxetine reduces serotonin transporter mRNA and 5HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus. Neuropsychopharmacology 15:515-522.
64. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwin GM, Smith CAD (1996) Polymorphism in serotonin transporter gene associated with suseptibility to major depression. Lancet 347:731-733.
65. Owens MJ (1996) Molecular and cellular mechanisms of antidepressant drugs. Depress Anxiety 4:153-159.
66. 2A receptor binding after chronic hypercorticosteronemia, (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat. J Pharmacol Exp Ther 278:1040-1048.
67. Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clinical Chemistry 40:288-295.
68. Owens MJ, Ritchie JC, Kilts CD (1997a) Clinical neurochemistry. In Charney DS, Nestler EJ, Bunney BS (eds): The Neurobiological Foundations of Mental Illness. New York: Oxford University Press, (in press).
69. Owens MJ, Morgan WN, Plott SM, Nemeroff CB (1997b) Receptor and transporter binding profile of modern antidepressants and their metabolites. J Pharmacol Exp Ther (in press).
70. 3H-imipramine to the platelet serotonin "transporter." Arch Gen Psychiatry 38:1315-1317.
71. Perry EK, Marshall EF, Blessed G, Tomlinson BE, Perry RH (1983) Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry 142:188-192.
72. 3H]imipramine binding in adolescents who attempted suicide. Am J Psychiatry 152:923-925.
73. Piñeyro G, Blier P, Dennis T, de Montigny C (1994) Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14:3036-3047.
74. Pletscher A (1987) The 5-hydroxytryptamine system of blood platelets: Physiology and pathophysiology. Int J Cardiol 14:177-188.
75. Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD (1995) Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 15:1201-1274.
76. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-57.
77. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD (1993) Antidepressantand cocaine-sensitive human serotonin transporter- Molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542-2546.
78. Roy A, De Jong J, Linnoila M (1989) Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. Arch Gen Psychiatry 46:609-612.
79. Rudnick G, Wall SC (1992a) The molecular mechanism of "ecstasy" [3,4-methylenedioxymethamphetamine (MDMA)]: Serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89:1817-1821.
80. Rudnick G, Wall SC (1992b) P-chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 31:6710-6718.
81. Rudnick G, Wall SC (1993) Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters. Mol Pharmacol 43:271-276.
82. Salomon RM, Miller HL, Krystal JH, Heninger GR, Charney DS (1997) Lack of effects of monoamine depletion in healthy subjects. Biol Psychiatry 41:58-64.
83. Slotkin TA, McCook EC, Ritchie JC, Seidler FJ (1996) Do glucocorticoids contribute to the abnormalities in serotonin transporter expression and function seen in depression? An animal model. Biol Psychiatry 40:576-584.
84. Slotkin TA, McCook EC, Ritchie JC, Carroll BJ, Seidler FJ (1997) Serotonin transporter expression in rat brain regions and blood platelets: Aging and glucocorticoid effects. Biol Psychiatry 41:172-183.
85. Soria PR, Vallejo J, Oros M, Menchon JM, Cortadellas T, Navarro MA, Urretavizcaya M (1996) Seasonal variability in blood platelet 3H-imipramine binding in healthy controls: Age and gender effects. Biol Psychiatry 40:981-985.
86. Spurlock G, Buckland P, O'Donovan M, McGuffin P (1994) Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33:433-440.
87. 3H]imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1337-1339.
88. Stöber G, Heils A, Lesch KP (1996) Serotonin transporter gene polymorphism and affective disorder. Lancet 347:1340-1341.
89. 3H-imipramine binding: A state-dependent marker in depression. Prog Neuropsychopharmacol Biol Psychiatry 8:737-741.
90. 3H]-IMI platelet binding and clinical response in major depression? Neuropsychopharmacology 14:47-53.
91. 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder. J Affect Dis 20:101-103.